Millennium Management’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding CPRX
GCL
HI
Millennium Management's CPRX Position: Q2 2026 in Review
Millennium Management increased its Catalyst Pharmaceutical (CPRX) stake by 39% in Q2 2026, buying an estimated $8.91M and bringing the position to 1,068,724 shares worth $33.6M. The position accounts for 0.01% of the portfolio, ranked #1188.
Millennium Management first reported a position in CPRX in Q3 2014 and has held it in 43 quarters since. The position peaked at $43M in Q4 2022. 395 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.
- Millennium Management held 1,068,724 shares of Catalyst Pharmaceutical worth $33.6M as of Q2 2026.
- Millennium Management bought 301,733 Catalyst Pharmaceutical shares in Q2 2026, an estimated $8.91M.
- Catalyst Pharmaceutical made up 0.01% of Millennium Management's portfolio in Q2 2026, its #1188 holding.
- Millennium Management first reported a position in Catalyst Pharmaceutical in Q3 2014 and has held it in 43 quarters since.
- Millennium Management's Catalyst Pharmaceutical position peaked at $43M in Q4 2022.
- 395 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.
Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.